The Patent Finder
US

Substituted Aminothiazoles as Dgkzeta Inhibitors for Immune Activation

US 12,673,927 In force, term unresolved
OverviewFamilyAssignmentsSources & methods

Term ends no later than Dec 18, 2042 · Medium confidence

In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.

Filed Oct 21, 2022 as application 17/920,679 · Granted Jul 7, 2026
Base term plus 607 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2021 2042
Clock starts
Apr 20, 2021
Ends no later than
Dec 18, 2042
Granted
Jul 7, 2026
base term patent term adjustment Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
607
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Unresolved
Terminal disclaimer
On file, reference document not resolved, so the date above is an upper bound. We do not guess the cap.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term runs 607 days past its 20-year base term on prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. 0 of 3 maintenance fees are paid so far. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Apr 20, 2021, when application PCT/EP2021/060167, the earliest non-provisional in its chain, was filed (this one was filed Oct 21, 2022)Apr 20, 2041High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+607 days, USPTO patent term adjustment recordDec 18, 2042High confidence
Terminal disclaimer capDisclaimer on file (approved), reference document not resolvedno cap applied, and none guessedMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events0 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderno later than Dec 18, 2042Medium confidence

Partial family

Application PCT/EP2021/060167PCT application
no patent term
no patent term
US 11,964,953In force
Apr 2041
Apr 2041
US 12,673,927this patent
no later than Dec 2042
no later than Dec 2042
Partial: 1 of the 3 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Mar 21, 2025
Reel 70587, frame 282
Nuvisan Icb GmbHBayer AktiengesellschaftAssignment of Assignor's Interest
Mar 21, 2025
Reel 70587, frame 527
Nowak-reppel, KatrinNuvisan Icb GmbHAssignment of Assignor's Interest
Mar 21, 2025
Reel 70587, frame 598
Röhn, Ulrike; Bömer, Ulf; Stöckigt, Detlef; Kosemund, DirkNuvisan Icb GmbHAssignment of Assignor's Interest
Mar 21, 2025
Reel 70587, frame 613
Offringa, Rienk; Link, CorinnaDeutsches KrebsforschungszentrumAssignment of Assignor's Interest
Mar 21, 2025
Reel 70587, frame 779
Grees, MareikeDeutsches KrebsforschungszentrumAssignment of Assignor's Interest
Mar 21, 2025
Reel 70588, frame 23
Rosentreter, UlrichBayer Pharma AktiengesellschaftAssignment of Assignor's Interest
Mar 21, 2025
Reel 70588, frame 26
Schmees, Norbert; Kirchhoff, Dennis; Petersen, Kirstin; Nguyen, Thi Thanh Uyen; Werbeck, Nicolas; Bader, BenjaminBayer AktiengesellschaftAssignment of Assignor's Interest
Mar 21, 2025
Reel 70588, frame 264
Röhn, Ulrike; Grees, Mareike; Bömer, Ulf; Stöckigt, Detlef; Kosemund, DirkBayer AktiengesellschaftAssignment of Assignor's Interest
Mar 21, 2025
Reel 70588, frame 271
Bayer Pharma AktiengesellschaftBayer AktiengesellschaftAssignment of Assignor's Interest
May 19, 2026
Reel 74700, frame 637
Bayer AktiengesellschaftDeutsches KrebsforschungszentrumAssignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited